Logo image of CARM.PA

CARMILA (CARM.PA) Stock Fundamental Analysis

Europe - EPA:CARM - FR0010828137 - REIT

17.06 EUR
-0.1 (-0.58%)
Last: 10/17/2025, 5:29:58 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to CARM. CARM was compared to 39 industry peers in the Diversified REITs industry. While CARM has a great profitability rating, there are some minor concerns on its financial health. CARM scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year CARM was profitable.
CARM had a positive operating cash flow in the past year.
CARM had positive earnings in 4 of the past 5 years.
In the past 5 years CARM always reported a positive cash flow from operatings.
CARM.PA Yearly Net Income VS EBIT VS OCF VS FCFCARM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

Looking at the Return On Assets, with a value of 5.24%, CARM belongs to the top of the industry, outperforming 89.74% of the companies in the same industry.
The Return On Equity of CARM (10.53%) is better than 92.31% of its industry peers.
CARM has a better Return On Invested Capital (4.91%) than 87.18% of its industry peers.
CARM had an Average Return On Invested Capital over the past 3 years of 3.52%. This is in line with the industry average of 3.49%.
The 3 year average ROIC (3.52%) for CARM is below the current ROIC(4.91%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.24%
ROE 10.53%
ROIC 4.91%
ROA(3y)2.69%
ROA(5y)1.6%
ROE(3y)5.18%
ROE(5y)3.03%
ROIC(3y)3.52%
ROIC(5y)3.08%
CARM.PA Yearly ROA, ROE, ROICCARM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

CARM has a better Profit Margin (64.32%) than 71.79% of its industry peers.
CARM's Profit Margin has improved in the last couple of years.
CARM's Operating Margin of 87.92% is amongst the best of the industry. CARM outperforms 92.31% of its industry peers.
CARM's Operating Margin has improved in the last couple of years.
CARM has a Gross Margin (72.59%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CARM has remained more or less at the same level.
Industry RankSector Rank
OM 87.92%
PM (TTM) 64.32%
GM 72.59%
OM growth 3Y17.79%
OM growth 5Y7.19%
PM growth 3Y11.44%
PM growth 5Y20.21%
GM growth 3Y2.7%
GM growth 5Y-0.75%
CARM.PA Yearly Profit, Operating, Gross MarginsCARM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150 200

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CARM is destroying value.
The number of shares outstanding for CARM has been reduced compared to 1 year ago.
CARM has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CARM has an improved debt to assets ratio.
CARM.PA Yearly Shares OutstandingCARM.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
CARM.PA Yearly Total Debt VS Total AssetsCARM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 0.97, we must say that CARM is in the distress zone and has some risk of bankruptcy.
CARM's Altman-Z score of 0.97 is fine compared to the rest of the industry. CARM outperforms 61.54% of its industry peers.
CARM has a debt to FCF ratio of 8.32. This is a slightly negative value and a sign of low solvency as CARM would need 8.32 years to pay back of all of its debts.
The Debt to FCF ratio of CARM (8.32) is better than 94.87% of its industry peers.
CARM has a Debt/Equity ratio of 0.77. This is a neutral value indicating CARM is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.77, CARM is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 8.32
Altman-Z 0.97
ROIC/WACC0.96
WACC5.12%
CARM.PA Yearly LT Debt VS Equity VS FCFCARM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

CARM has a Current Ratio of 0.74. This is a bad value and indicates that CARM is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of CARM (0.74) is better than 64.10% of its industry peers.
CARM has a Quick Ratio of 0.74. This is a bad value and indicates that CARM is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.74, CARM is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.74
Quick Ratio 0.74
CARM.PA Yearly Current Assets VS Current LiabilitesCARM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 572.32% over the past year.
CARM shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.86% yearly.
The Revenue has grown by 17.64% in the past year. This is quite good.
CARM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.93% yearly.
EPS 1Y (TTM)572.32%
EPS 3Y18.46%
EPS 5Y22.86%
EPS Q2Q%46.39%
Revenue 1Y (TTM)17.64%
Revenue growth 3Y5.68%
Revenue growth 5Y2.93%
Sales Q2Q%16.35%

3.2 Future

CARM is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.04% yearly.
The Revenue is expected to grow by 3.79% on average over the next years.
EPS Next Y8.04%
EPS Next 2Y5.83%
EPS Next 3Y5.04%
EPS Next 5YN/A
Revenue Next Year10.42%
Revenue Next 2Y6.53%
Revenue Next 3Y3.79%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CARM.PA Yearly Revenue VS EstimatesCARM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
CARM.PA Yearly EPS VS EstimatesCARM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

8

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 6.85, which indicates a rather cheap valuation of CARM.
97.44% of the companies in the same industry are more expensive than CARM, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of CARM to the average of the S&P500 Index (27.29), we can say CARM is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 9.04, the valuation of CARM can be described as reasonable.
79.49% of the companies in the same industry are more expensive than CARM, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of CARM to the average of the S&P500 Index (22.85), we can say CARM is valued rather cheaply.
Industry RankSector Rank
PE 6.85
Fwd PE 9.04
CARM.PA Price Earnings VS Forward Price EarningsCARM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

94.87% of the companies in the same industry are more expensive than CARM, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CARM is valued cheaply inside the industry as 87.18% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.16
EV/EBITDA 10.49
CARM.PA Per share dataCARM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

CARM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CARM has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)0.85
PEG (5Y)0.3
EPS Next 2Y5.83%
EPS Next 3Y5.04%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.47%, CARM is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.56, CARM pays a better dividend. On top of this CARM pays more dividend than 87.18% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, CARM pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.47%

5.2 History

The dividend of CARM decreases each year by -4.29%.
Dividend Growth(5Y)-4.29%
Div Incr Years0
Div Non Decr Years0
CARM.PA Yearly Dividends per shareCARM.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

CARM pays out 50.04% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP50.04%
EPS Next 2Y5.83%
EPS Next 3Y5.04%
CARM.PA Yearly Income VS Free CF VS DividendCARM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M
CARM.PA Dividend Payout.CARM.PA Dividend Payout, showing the Payout Ratio.CARM.PA Dividend Payout.PayoutRetained Earnings

CARMILA

EPA:CARM (10/17/2025, 5:29:58 PM)

17.06

-0.1 (-0.58%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)07-23 2025-07-23
Earnings (Next)10-23 2025-10-23
Inst Owners34.14%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap2.40B
Analysts78.57
Price Target20.57 (20.57%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.47%
Yearly Dividend1.21
Dividend Growth(5Y)-4.29%
DP50.04%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.44%
PT rev (3m)1.54%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)1.01%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.93%
Revenue NY rev (3m)3.18%
Valuation
Industry RankSector Rank
PE 6.85
Fwd PE 9.04
P/S 4.39
P/FCF 7.16
P/OCF 7.1
P/B 0.72
P/tB 0.72
EV/EBITDA 10.49
EPS(TTM)2.49
EY14.6%
EPS(NY)1.89
Fwd EY11.06%
FCF(TTM)2.38
FCFY13.96%
OCF(TTM)2.4
OCFY14.08%
SpS3.89
BVpS23.74
TBVpS23.73
PEG (NY)0.85
PEG (5Y)0.3
Profitability
Industry RankSector Rank
ROA 5.24%
ROE 10.53%
ROCE 7.65%
ROIC 4.91%
ROICexc 5%
ROICexgc 5%
OM 87.92%
PM (TTM) 64.32%
GM 72.59%
FCFM 61.25%
ROA(3y)2.69%
ROA(5y)1.6%
ROE(3y)5.18%
ROE(5y)3.03%
ROIC(3y)3.52%
ROIC(5y)3.08%
ROICexc(3y)3.79%
ROICexc(5y)3.29%
ROICexgc(3y)3.79%
ROICexgc(5y)3.29%
ROCE(3y)5.48%
ROCE(5y)4.8%
ROICexcg growth 3Y20.72%
ROICexcg growth 5Y9%
ROICexc growth 3Y20.74%
ROICexc growth 5Y9.01%
OM growth 3Y17.79%
OM growth 5Y7.19%
PM growth 3Y11.44%
PM growth 5Y20.21%
GM growth 3Y2.7%
GM growth 5Y-0.75%
F-Score5
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 8.32
Debt/EBITDA 5.3
Cap/Depr 68.54%
Cap/Sales 0.52%
Interest Coverage 3.91
Cash Conversion 69.65%
Profit Quality 95.22%
Current Ratio 0.74
Quick Ratio 0.74
Altman-Z 0.97
F-Score5
WACC5.12%
ROIC/WACC0.96
Cap/Depr(3y)129.75%
Cap/Depr(5y)102.72%
Cap/Sales(3y)1.8%
Cap/Sales(5y)1.14%
Profit Quality(3y)3321.64%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)572.32%
EPS 3Y18.46%
EPS 5Y22.86%
EPS Q2Q%46.39%
EPS Next Y8.04%
EPS Next 2Y5.83%
EPS Next 3Y5.04%
EPS Next 5YN/A
Revenue 1Y (TTM)17.64%
Revenue growth 3Y5.68%
Revenue growth 5Y2.93%
Sales Q2Q%16.35%
Revenue Next Year10.42%
Revenue Next 2Y6.53%
Revenue Next 3Y3.79%
Revenue Next 5YN/A
EBIT growth 1Y69.71%
EBIT growth 3Y24.48%
EBIT growth 5Y10.33%
EBIT Next Year7.42%
EBIT Next 3Y4.73%
EBIT Next 5Y2.86%
FCF growth 1Y20.89%
FCF growth 3Y4.44%
FCF growth 5Y0.82%
OCF growth 1Y20.76%
OCF growth 3Y4.74%
OCF growth 5Y1.02%